Frazier Life Sciences Ix, L.P. Tarsus Pharmaceuticals, Inc. (TARS) insider trading activity
Frazier Life Sciences Ix, L.P. is > 10% Shareholder of Tarsus Pharmaceuticals, Inc.. Currently has a direct ownership of 1.92 Million shares of TARS, which is worth approximately $105 Million. The most recent transaction as insider was on Oct 20, 2020, when has been sold 312,500 shares (Common Stock) at a price of $16.0 per share, resulting in proceeds of $5,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.92M
0%
3M change
0%
12M change
Total Value Held
$105 Million
Frazier Life Sciences IX, L.P. Transaction History
FLS
Frazier Life Sciences Ix, L.P.
> 10% Shareholder
Seattle, WA